VivoPower PLC (VIVO)
NASDAQ: VIVO · Real-Time Price · USD
1.890
-0.180 (-8.70%)
At close: Mar 16, 2026, 4:00 PM EDT
1.900
+0.010 (0.53%)
After-hours: Mar 16, 2026, 5:31 PM EDT
VivoPower Revenue
In the fiscal year ending June 30, 2025, VivoPower had annual revenue of $61.00K with 281.25% growth. VivoPower had revenue of $-2.00K in the half year ending June 30, 2025.
Revenue (ttm)
$61.00K
Revenue Growth
+281.25%
P/S Ratio
489.92
Revenue / Employee
$1,488
Employees
41
Market Cap
31.73M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 61.00K | 45.00K | 281.25% |
| Jun 30, 2024 | 16.00K | -4.04M | -99.61% |
| Jun 30, 2023 | 4.05M | -6.11M | -60.09% |
| Jun 30, 2022 | 10.16M | -13.82M | -57.62% |
| Jun 30, 2021 | 23.98M | -9.15M | -27.63% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Johnson & Johnson | 94.19B |
| Eli Lilly and Company | 65.18B |
| AbbVie | 61.16B |
| AstraZeneca | 58.74B |
| Exicure | 500.00K |
| Hyperion DeFi | 345.32K |
VIVO News
- 11 hours ago - VivoPower Announces Effectiveness of New Stock Ticker “VIVO” and Corporate Name Change - GlobeNewsWire
- 20 days ago - Meridian Bioscience Achieves IVDR Certification for Alethia® Molecular Assay Portfolio - Business Wire
- 3 years ago - SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience - PRNewsWire
- 3 years ago - Meridian Bioscience Announces Anticipated Closing Date of the Pending Merger - PRNewsWire
- 3 years ago - MERIDIAN BIOSCIENCE REPORTS FOURTH QUARTER AND FULL YEAR FISCAL 2022 OPERATING RESULTS - PRNewsWire
- 3 years ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TMX, VIVO, RFP, SBTX - PRNewsWire
- 3 years ago - SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates RFP, VIVO, EGY, STCN - PRNewsWire
- 3 years ago - SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates BHVN, VIVO, HNGR, CMAX - PRNewsWire